Readout Newsletter: Roche, Vertex, and J.D. Vance updates
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
UBS Navigates a Pivotal Week of Payouts, Policy, and Performance
UBS shareholders receive dividend as new board takes over, while a Swiss regulatory decision could impose up to…
UBS Shares Face Pressure Amid Trade Policy Shifts
UBS faces a critical month with Q1 earnings testing its post-merger strategy amid U.S. tariff headwinds and Swiss…
UBS Shares Face Pressure Amid Trade Policy Shifts
UBS faces a critical month with Q1 earnings testing its post-merger strategy amid U.S. tariff headwinds and Swiss…
US Tariff Policy Pressures Novartis to Reshore Pharmaceutical Production
US proposes 100% tariffs on patented drugs, forcing Novartis to reshore manufacturing with a $23B investment and stockpiling…
Alpine Connectivity: How Mobile Networks Perform Across Europe’s Premier Ski Resorts
Austria leads on the slopes, where Alpine-specific auction incentives, public co-funding, and deep low-band spectrum holdings drive superior…
Roche Restricts Consulting Work With Big Four Firms to Cut Costs
Roche Holding AG is reining in spending with the Big Four accounting firms and will require any future…
Geneva Strategic Plan lays groundwork for addressing priorities | News
GENEVA — On Saturday, City Council will host the first of two sessions on its draft 2026 Strategic…
Roche Restricts Consulting Work With Big Four Firms to Cut Costs
Roche Holding AG is reining in spending with the Big Four accounting firms and will require any future…
Human rights compliance and Pakistan’s GSP+ in focus at Geneva UNHRC event
Geneva [Switzerland], March 14 (ANI): A side event during the 61st Session of the United Nations Human Rights…
Breast Cancer (BC) | Novartis U.S.
Addressing the different needs around metastatic disease: Making life more than a diagnosis Any breast cancer diagnosis can…
Roche suffers a fresh blow as India’s Supreme Court allows generic sales of its pricey rare disease drug
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which…